Haj. Schut et al., DNA-ADDUCTS OF HETEROCYCLIC AMINES - FORMATION, REMOVAL AND INHIBITION BY DIETARY-COMPONENTS, Mutation research, 376(1-2), 1997, pp. 185-194
The dietary mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) are carcinogeni
c in rodents. In F344 rats PhIP induces mammary tumors in females and
colon tumors in males, while IQ induces tumors principally in the live
r, Zymbal gland and intestines. In CDF1 mice, IQ induces liver, lung a
nd forestomach tumors. We have evaluated the dynamics of formation, re
moval and inhibition of PhIP- and IQ-DNA adducts in these rodents. Aft
er bolus doses (50 mg/kg, by gavage) of IQ or PhIP, both IQ- and PhIP-
DNA adducts were removed rapidly from both target and nontarget organs
, while after 3-4 weeks of feeding IQ or PhIP (0.01-0.04%) adduct remo
val was much slower. Gavaging of male F344 rats with PhIP (0.1-1000 mu
g/kg/day) for 23 days resulted in accumulation of PhIP-DNA adducts in
various organs, but adducts were detectable only at 100 or 1000 mu g/
kg/day. Urinary excretion of unchanged PhIP was a constant proportion
(1.6-2.1%) of the daily dose over the entire dose range and was indepe
ndent of duration of exposure. When weanling female F344 rats were exp
osed to dietary PhIP (0.01-0.04%) for 1-4 weeks, the presence of eithe
r conjugated linoleic acid (CLA; 0.1-1.0%) or indole-3-carbinol (I3C;
0.1%) in the diet inhibited PhIP-DNA adduct formation (58-99%) in vari
ous organs, including the mammary gland and the colon. Similarly, the
inclusion of 0.075% 4-ipomeanol (IPO) in the diet of male CDF1 mice ex
posed for 3 weeks to dietary IQ (0.01%) resulted in inhibition of IQ-D
NA adduct formation (30-59%) in the target organs (liver, lungs, stoma
ch) but not in a number of other organs. It is concluded that (1) the
rate of PhIP- and IQ-DNA adduct removal depends on the dose and freque
ncy of administration, (2) urinary PhIP may be a good biomarker of rec
ent PhIP exposure and (3) CLA, I3C and LPO are potential chemopreventi
ve agents against PhIP- or IQ-induced tumors in rodents.